The actual history of these Confederate statues explains why they should come down.

Robert E. Lee, Jefferson Davis, and P.G.T. Beauregard were responsible for a war that killed more than 600,000 Americans to defend the right to keep millions more enslaved.

Years after the end of that war, the City of New Orleans honored each of the three men with a statue.

Recently, those statues finally came down.


A statue of Robert E. Lee is removed in New Orleans. Photo by Scott Threlkeld/AP.

Mayor Mitch Landrieu delivered an emotional speech commemorating the day Lee's statue was removed from its home in Lee Circle where it had stood for 133 years.

New Orleans Mayor Mitch Landrieu. Photo by Cliff Owen/AP.

Landrieu's speech is remarkable not for its full-throated condemnation of the Confederate figures memorialized in stone, but for addressing why the statues were put there in the first place.

Critics of the move to take the memorials down, which was approved by the city council, insist the statues represent New Orleans' "heritage," and their removal is tantamount to "denying history."

Landrieu's argument — one backed by a growing historical consensus — was that the monuments were not erected as sober tributes to fallen military leaders, but as a political act, decades after the Civil War, in a conscious attempt to whitewash the past.

"The historic record is clear: the Robert E. Lee, Jefferson Davis, and P.G.T. Beauregard statues were not erected just to honor these men, but as part of the movement which became known as The Cult of the Lost Cause. This ‘cult’ had one goal — through monuments and through other means — to rewrite history to hide the truth, which is that the Confederacy was on the wrong side of humanity."

With the end of Reconstruction, which abortively attempted to establish political equality for blacks throughout the South, lawmakers throughout the region began valorizing Confederate figures to assert white control while simultaneously playing down those figures' ties to slavery.

Photo by Kevin McGill/AP.

A 2016 study undertaken by the Southern Poverty Law Center found over 1,500 such public memorials spread across the United States. As Landrieu stated:

"After the Civil War, these statues were a part of that terrorism as much as a burning cross on someone’s lawn; they were erected purposefully to send a strong message to all who walked in their shadows about who was still in charge in this city."

A fourth statue that came down commemorated the Battle of Liberty Place, in which white supremacist vigilantes overran New Orleans, ousting the state's integrationist government for several days.

An inscription on the original Liberty Place monument read: "United States troops took over the state government and reinstated the usurpers but the national election November 1876 recognized white supremacy in the South and gave us our state."

In his speech, Landrieu acknowledged that many of his constituents are emotionally attached to the statues, though they might not be fully aware of the context surrounding their construction.

Protestors rally against removing Confederate monuments. Photo by Justin Sullivan/Getty Images.

The mayor, compassionately, refused to criticize those who support keeping the memorials in place, stressing the importance of learning and maturing:

"So I am not judging anybody, I am not judging people. We all take our own journey on race. I just hope people listen like I did when my dear friend Wynton Marsalis helped me see the truth. He asked me to think about all the people who have left New Orleans because of our exclusionary attitudes."

He continued by asking those protesting the monuments' removal to consider them from the perspective of others, particularly those whose families were affected by the evil legacy of slavery and segregation.

"Another friend asked me to consider these four monuments from the perspective of an African American mother or father trying to explain to their fifth grade daughter who Robert E. Lee is and why he stands atop of our beautiful city. Can you do it?"

There's no easy way to reconcile two versions of history.

The only way to do so is by, as Landrieu asserted, grappling with the past honestly and openly.

Often, the process is slow and painful. It involves acknowledging mistakes, empathizing with others, and letting go of deeply rooted beliefs.

The former site of Jefferson Davis' statue in New Orleans, where the word "love" has replaced the monument. Photo by Kevin McGill/AP.

Occasionally, if done meticulously and assiduously, it can lead to lasting reconciliation.

From 1861 to 1865, Confederate leaders, like Robert E. Lee, Jefferson Davis, and P.G.T. Beauregard, fought to keep human beings as property. The following century saw political leaders throughout the United States fighting to deny those same human beings full citizenship — a struggle memorialized by the statues that, until recently, loomed over the city of New Orleans.

Taking down the statues, Landrieu insists, is a necessary first step toward making his community — now inhabited by the descendants of both enslaved people and those who kept them in chains — whole.

"Centuries-old wounds are still raw because they never healed right in the first place," he said in the speech.

Here's hoping that starts now.

You can (and should) read the full speech here.

via PeopleStanding / Instagram

One of the best things about social media is that there are some pages that deputize the general public to find great content and submit it to be published. It's like harnessing a mind-hive of funny to create a place where it can be enjoyed by everyone.

The People Standing page on Instagram is a great example of this type of crowdsourcing for comedy. The site has over 140,000 followers and features candid, user-submitted pictures of people standing awkwardly that were taken all over the globe.

Here are 17 of the best.

Keep Reading Show less
via PeopleStanding / Instagram

One of the best things about social media is that there are some pages that deputize the general public to find great content and submit it to be published. It's like harnessing a mind-hive of funny to create a place where it can be enjoyed by everyone.

The People Standing page on Instagram is a great example of this type of crowdsourcing for comedy. The site has over 140,000 followers and features candid, user-submitted pictures of people standing awkwardly that were taken all over the globe.

Here are 17 of the best.

Keep Reading Show less
True

Each year, an estimated 1.8 million people in the United States are affected by cancer — most commonly cancers of the breast, lung, prostate, and blood cancers such as leukemia. While not everyone overcomes the disease, thanks to science, more people are surviving — and for longer — than ever before in history.

We asked three people whose lives have been impacted by cancer to share their stories – how their lives were changed by the disease, and how they're using that experience to change the future of cancer treatments with the hope that ultimately, in the fight against cancer, science will win. Here's what they had to say.

Celine Ryan, 55, engineer database programmer and mother of five from Detroit, MI

Photo courtesy of Celine Ryan

In September 2013, Celine Ryan woke up from a colonoscopy to some traumatic news. Her gastroenterologist showed her a picture of the cancerous mass they found during the procedure.

Ryan and her husband, Patrick, had scheduled a colonoscopy after discovering some unusual bleeding, so the suspicion she could have cancer was already there. Neither of them, however, were quite prepared for the results to be positive -- or for the treatment to begin so soon. Just two days after learning the news, Ryan had surgery to remove the tumor, part of her bladder, and 17 cancerous lymph nodes. Chemotherapy and radiation soon followed.

Ryan's treatment was rigorous – but in December 2014, she got the devastating news that the cancer, once confined to her colon, had spread to her lungs. Her prognosis, they said, was likely terminal.

But rather than give up hope, Ryan sought support from online research, fellow cancer patients and survivors, and her medical team. When she brought up immunotherapy to her oncologist, he quickly agreed it was the best course of action. Ryan's cancer, like a majority of colon and pancreatic cancers, had been caused by a defect on the gene KRAS, which can result in a very aggressive cancer that is virtually "undruggable." According to the medical literature, the relatively smooth protein structure of the KRAS gene meant that designing inhibitors to bind to surface grooves and treat the cancer has been historically difficult. Through her support systems, Ryan discovered an experimental immunotherapy trial at the National Institutes of Health (NIH) in Bethesda, MD., and called them immediately to see if she was eligible. After months of trying to determine whether she was a suitable candidate for the experimental treatment, Ryan was finally accepted.

The treatment, known as tumor-infiltrating lymphocyte therapy, or TIL, is a testament to how far modern science has evolved. With this therapy, doctors remove a tumor and harvest special immune cells that are found naturally in the tumor. Doctors then grow the cells in a lab over the next several weeks with a protein that promotes rapid TIL growth – and once the cells number into the billions, they are infused back into the patient's body to fight the cancer. On April 1, 2015, Ryan had her tumor removed at the NIH. Two months later, she went inpatient for four weeks to have the team "wash out" her immune system with chemotherapy and infuse the cells – all 148 billion of them – back into her body.

Six weeks after the infusion, Ryan and Patrick went back for a follow-up appointment – and the news they got was stunning: Not only had no new tumors developed, but the six existing tumors in her lungs had shrunk significantly. Less than a year after her cell infusion, in April 2016, the doctors told Ryan news that would have been impossible just a decade earlier: Thanks to the cell infusion, Ryan was now considered NED – no evaluable disease. Her body was cancer-free.

Ryan is still NED today and continuing annual follow-up appointments at the NIH, experiencing things she never dreamed she'd be able to live to see, such as her children's high school and college graduations. She's also donating her blood and cells to the NIH to help them research other potential cancer treatments. "It was an honor to do so," Ryan said of her experience. "I'm just thrilled, and I hope my experience can help a lot more people."

Patrice Lee, PhD, VP of Pharmacology, Toxicology and Exploratory Development at Pfizer

Photo courtesy of Patrice Lee

Patrice Lee got into scientific research in an unconventional way – through the late ocean explorer Jacques Cousteau.

Lee never met Cousteau but her dreams of working with him one day led her to pursue a career in science. Initially, Lee completed an undergraduate degree in marine biology; eventually, her interests changed and she decided to get a dual doctoral degree in physiology and toxicology at Duke University. She now works at Pfizer's R&D site in Boulder, CO (formerly Array BioPharma), leading a group of scientists who determine the safety and efficacy of new oncology drugs.

"Scientists focused on drug discovery and development in the pharmaceutical industry are deeply committed to inventing new therapies to meet unmet needs," Lee says, describing her field of work. "We're driven to achieve new medicines and vaccines as quickly as possible without sacrificing safety."

Among the drugs Lee has helped develop during her career, including cancer therapies, she says around a dozen are currently in development, while nine have received FDA approval — an incredible accomplishment as many scientists spend their careers without seeing their drug make it to market. Lee's team is particularly interested in therapies for brain metastases — something that Lee says is a largely unmet need in cancer research, and something her team is working on from a variety of angles. "Now that we've had rapid success with mRNA vaccine technology, we hope to explore what the future holds when applying this technology to cancers," Lee says.

But while evaluating potential cancer therapies is a professional passion of Lee's, it's also a mission that's deeply personal. "I'm also a breast cancer survivor," she says. "So I've been on the other side of things and have participated in a clinical trial."

However, seeing how melanoma therapies that she helped develop have affected other real-life cancer patients, she says, has been a highlight of her career. "We had one therapy that was approved for patients with BRAF-mutant metastatic melanoma," Lee recalls. "Our team in Boulder was graced by a visit from a patient that had benefited from these drugs that we developed. It was a very special moment for the entire team."

None of these therapies would be available, Lee says without rigorous science behind it: "Facts come from good science. Facts will drive the development of new drugs, and that's what will help patients."

Chiuying "Cynthia" Kuk (they/them) MS, 34, third-year medical student at Michigan State University College of Human Medicine

Photo courtesy of Cynthia Kuk

Cynthia Kuk was just 10 years old when they had a conversation that would change their life forever.

"My mother, who worked as a translator for the government at the time, had been diagnosed with breast cancer, and after her chemotherapy treatments she would get really sick," Kuk, who uses they/them pronouns, recalls. "When I asked my dad why mom was puking so much, he said it was because of the medicine she was taking that would help her get better."

Kuk's response was immediate: "That's so stupid! Why would a medicine make you feel worse instead of better? When I'm older, I want to create medicine that won't make people sick like that."

Nine years later, Kuk traveled from their native Hong Kong to the United States to do exactly that. Kuk enrolled in a small, liberal arts college for their Bachelor's degree, and then four years later started a PhD program in cancer research. Although Kuk's mother was in remission from her cancer at the time, Kuk's goal was the same as it had been as a 10-year-old watching her suffer through chemotherapy: to design a better cancer treatment, and change the landscape of cancer research forever.

Since then, Kuk's mission has changed slightly.

"My mom's cancer relapsed in 2008, and she ended up passing away about five years after that," Kuk says. "After my mom died, I started having this sense of urgency. Cancer research is such that you work for twenty years, and at the end of it you might have a fancy medication that could help people, but I wanted to help people now." With their mother still at the forefront of their mind, Kuk decided to quit their PhD program and enter medical school.

Now, Kuk plans to pursue a career in emergency medicine – not only because they are drawn to the excitement of the emergency room, but because the ER is a place where the most marginalized people tend to seek care.

"I have a special interest in the LGBTQ+ population, as I identify as queer and nonbinary," says Kuk. "A lot of people in this community and other marginalized communities access care through the ER and also tend to avoid medical care since there is a history of mistreatment and judgement from healthcare workers. How you carry yourself as a doctor, your compassion, that can make a huge difference in someone's care."

In addition to making a difference in the lives of LGBTQ+ patients, Kuk wants to make a difference in the lives of patients with cancer as well, like their mother had.

"We've diagnosed patients in the Emergency Department with cancer before," Kuk says. "I can't make cancer good news but how you deliver bad news and the compassion you show could make a world of difference to that patient and their family."

During their training, Kuk advocates for patients by delivering compassionate and inclusive care, whether they happen to have cancer or not. In addition to emphasizing their patient's pronouns and chosen names, they ask for inclusive social and sexual histories as well as using gender neutral language. In doing this, they hope to make medicine as a whole more accessible for people who have been historically pushed aside.

"I'm just one person, and I can't force everyone to respect you, if you're marginalized," Kuk says. "But I do want to push for a culture where people appreciate others who are different from them."